Perrigo Recalls 11 Million Bottles of Acetaminophen - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Perrigo Recalls 11 Million Bottles of Acetaminophen


ePT--the Electronic Newsletter of Pharmaceutical Technology

Untitled Document

Allegan, MI (Nov. 9)—Over-the-counter drug maker Perrigo Company (www.perrigo.com) issued a voluntary recall of certain lots of store-brand acetaminophen 500-mg caplets that could contain trace amounts of metal particulate. Approximately 11 million bottles of acetaminophen are affected by the recall.

After discovering that its tableting equipment was wearing down prematurely, Perrigo reported the contamination to the US Food and Drug Administration on Nov. 2, 2006. The company told Pharmaceutical Technology that the unusual wear was detected and investigated through the company’s internal quality-control procedures. An investigation found metal particulate contamination and traced it back to a third-party supplier of a raw material.

In the investigation, Perrigo reported, 70 million caplets were passed through a metal detector and 200 caplets were found to contain metal fragments. The size of the particles ranged from "microdots" to 8 mm in length. To date, no serious health effects have been reported, but tablets containing metal particles could cause stomach discomfort and possible cuts to the mouth or throat.

 

 

ADVERTISEMENT

RELATED CONTENT
Warning Letters Demand Stop to Unapproved Ergotamine Manufacture and Distribution
Maintain Your Moving Parts
FDA Issues Warning Letter to Bell-More Laboratories
BIO Raises Concerns Over Studies on Follow-on Biologics
Actavis receives FDA Warning Letter
post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
22%
In Western Europe
18%
In Central and Eastern Europe
3%
In Japan
2%
In India
28%
In China
28%
View Results
Jim MillerOutsourcing OutlookJim Miller Time for a Model Upgrade
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Navigating the Global Pharmaceutical Supply Chain
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
Biopharmaceutical Collaboration Is a Sign of the Times
Life After Big Pharma
PhRMA Details Its Proposal for Internet and Social-Media Standards
The Unregulated Regulator
Rx-360 Goals Get off the Ground
FindPharma Custom Search
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here